BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37338557)

  • 21. Diagnostic performance rates of the ACR-TIRADS and EU-TIRADS based on histopathological evidence.
    Hekimsoy İ; Öztürk E; Ertan Y; Orman MN; Kavukçu G; Özgen AG; Özdemir M; Özbek SS
    Diagn Interv Radiol; 2021 Jul; 27(4):511-518. PubMed ID: 34313236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Explore the Diagnostic Efficiency of Chinese Thyroid Imaging Reporting and Data Systems by Comparing With the Other Four Systems (ACR TI-RADS, Kwak-TIRADS, KSThR-TIRADS, and EU-TIRADS): A Single-Center Study.
    Qi Q; Zhou A; Guo S; Huang X; Chen S; Li Y; Xu P
    Front Endocrinol (Lausanne); 2021; 12():763897. PubMed ID: 34777258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound malignancy risk stratification of thyroid nodules based on the degree of hypoechogenicity and echotexture.
    Lee JY; Na DG; Yoon SJ; Gwon HY; Paik W; Kim T; Kim JY
    Eur Radiol; 2020 Mar; 30(3):1653-1663. PubMed ID: 31732777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of British Thyroid Association, American College of Radiology TIRADS and Artificial Intelligence TIRADS with histological correlation: diagnostic performance for predicting thyroid malignancy and unnecessary fine needle aspiration rate.
    Watkins L; O'Neill G; Young D; McArthur C
    Br J Radiol; 2021 Jul; 94(1123):20201444. PubMed ID: 33989038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules.
    Tuli G; Munarin J; Scollo M; Quaglino F; De Sanctis L
    Front Endocrinol (Lausanne); 2022; 13():1041464. PubMed ID: 36482990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison among TIRADS (ACR TI-RADS and KWAK- TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules.
    Gao L; Xi X; Jiang Y; Yang X; Wang Y; Zhu S; Lai X; Zhang X; Zhao R; Zhang B
    Endocrine; 2019 Apr; 64(1):90-96. PubMed ID: 30659427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Korean vs. American Thyroid Imaging Reporting and Data System in Malignancy Risk Assessment of Indeterminate Thyroid Nodules.
    Kang S; Kwon SK; Choi HS; Kim MJ; Park YJ; Park DJ; Cho SW
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1111-1120. PubMed ID: 34674501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Study of C-TIRADS, ACR-TIRADS, and EU-TIRADS for Diagnosis and Management of Thyroid Nodules.
    Jin Z; Pei S; Shen H; Ouyang L; Zhang L; Mo X; Chen Q; You J; Zhang S; Zhang B
    Acad Radiol; 2023 Oct; 30(10):2181-2191. PubMed ID: 37230821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison and preliminary discussion of the reasons for the differences in diagnostic performance and unnecessary FNA biopsies between the ACR TIRADS and 2015 ATA guidelines.
    Wu XL; Du JR; Wang H; Jin CX; Sui GQ; Yang DY; Lin YQ; Luo Q; Fu P; Li HQ; Teng DK
    Endocrine; 2019 Jul; 65(1):121-131. PubMed ID: 30830584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of diagnostic performance and FNA management of the ACR-TIRADS and Chinese-TIRADS based on surgical histological evidence.
    Dong W; Wu Y; Cai T; Wang X
    Quant Imaging Med Surg; 2023 Mar; 13(3):1711-1722. PubMed ID: 36915304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules.
    Zhou L; Zheng LL; Zhang CJ; Wei HF; Xu LL; Zhang MR; Li Q; He GF; Ghamor-Amegavi EP; Li SY
    Front Endocrinol (Lausanne); 2023; 14():1098031. PubMed ID: 36761203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and comparison of three newly-released Thyroid Imaging Reporting and Data Systems for cancer risk determination.
    Xu T; Wu Y; Wu RX; Zhang YZ; Gu JY; Ye XH; Tang W; Xu SH; Liu C; Wu XH
    Endocrine; 2019 May; 64(2):299-307. PubMed ID: 30474824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explore the diagnostic performance of 2020 Chinese Thyroid Imaging Reporting and Data Systems by comparing with the 2017 ACR-TIRADS guidelines: a single-center study.
    Cai M; Chen L; Shui L; Lv X; Wang H
    Endocrine; 2023 May; 80(2):399-407. PubMed ID: 36930437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound criteria (EU-TIRADS) to identify thyroid nodule malignancy risk in adolescents. Correlation with cyto-histological findings.
    Yeste Fernández D; Vega Amenabar E; Coma Muñoz A; Arciniegas Vallejo L; Clemente León M; Planes-Conangla M; Iglesias Felip C; Sábado Álvarez C; Guillén Burrieza G; Campos-Martorell A
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Dec; 68(10):728-734. PubMed ID: 34924161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System for Thyroid Nodule Malignancy Risk Stratification in a Pediatric Population.
    Lim-Dunham JE; Toslak IE; Reiter MP; Martin B
    AJR Am J Roentgenol; 2019 Jan; 212(1):188-194. PubMed ID: 30403525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agreement Between American and European Thyroid Imaging, Reporting, and Data System (TIRADS) in the Diagnosis of 473 Thyroid Nodules From a Single Center in Brazil.
    Freire da Silva P; Corrêa de Araújo Arcoverde L; de Siqueira Barbosa Arcoverde L; Tenório Wanderley Fernandes Lima G; Paes de Medeiros Lima T; José do Amaral F; Bandeira F
    Endocr Pract; 2021 Nov; 27(11):1108-1113. PubMed ID: 34153510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the diagnostic performance and clinical role of different ultrasound-based thyroid malignancy risk stratification systems for medullary thyroid carcinoma.
    Jiang L; Zhu HB; Liang ZW; Chen L; Sun XM; Shao YH; Chen LZ
    Quant Imaging Med Surg; 2023 Jun; 13(6):3776-3788. PubMed ID: 37284109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of diagnostic accuracy of ACR-TIRADS, American Thyroid Association (ATA), and EU-TIRADS guidelines in detecting thyroid malignancy.
    Koc AM; Adıbelli ZH; Erkul Z; Sahin Y; Dilek I
    Eur J Radiol; 2020 Dec; 133():109390. PubMed ID: 33181485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applying machine-learning models to differentiate benign and malignant thyroid nodules classified as C-TIRADS 4 based on 2D-ultrasound combined with five contrast-enhanced ultrasound key frames.
    Chen JH; Zhang YQ; Zhu TT; Zhang Q; Zhao AX; Huang Y
    Front Endocrinol (Lausanne); 2024; 15():1299686. PubMed ID: 38633756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Different Risk-Stratification Systems for the Diagnosis of Benign and Malignant Thyroid Nodules.
    Shen Y; Liu M; He J; Wu S; Chen M; Wan Y; Gao L; Cai X; Ding J; Fu X
    Front Oncol; 2019; 9():378. PubMed ID: 31139568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.